Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Craving & Decision-Making

NCT06440577 · View on ClinicalTrials.gov ↗

Study Summary

Craving is the strong desire for something, such as for substances in drug addiction and food or other activities in everyday life. Recent work suggests craving can influence how people make decisions and assign value to choice options available to them, yet the neural mechanisms underlying these interactions between craving and valuation remain unknown. To address this, this study uses cognitive decision-making tasks that measure how much individuals will pay (from a study endowment) to have everyday consumer items or snack foods when they crave something specific (opioids or a specific snack, respectively). First, the study will identify the neural mechanisms for how drug craving (craving for opioids) interacts with valuation for consumer items that have associations with drug use or not in people receiving treatment for opioid use disorder (OUD). This will be evaluated in the activity patterns and interactions among brain regions involved in craving and value assignment during decision-making. Then, the study will examine for parallel mechanisms for how food craving (craving for a specific snack) interacts with valuation for snack food items that have similar features to the craved snack or not in people receiving treatment for OUD and non-psychiatric community control participants.

Conditions Studied

Interventions

  • BEHAVIORAL Audio-visual stimuli (Neutral-Relaxing)
  • BEHAVIORAL Audio-visual stimuli (Drug)
  • BEHAVIORAL Audio-visual stimuli (Non-Food)
  • BEHAVIORAL Audio-visual stimuli (Food)

Study Locations (1)

New Jersey

  • Rutgers, The State University of New Jersey — Piscataway

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2024-06-18
Est. Completion 2026-12
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06440577

The ClinicalTrials.gov registry entry for NCT06440577 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 603 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Decision Making appearing as the primary indexed condition, and to 4 interventions — of which Audio-visual stimuli (Neutral-Relaxing) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06440577 reports 1 study location spanning 1 distinct geographic area — top geographies include New Jersey. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06440577 about?

NCT06440577 is a clinical study titled "Craving & Decision-Making". Craving is the strong desire for something, such as for substances in drug addiction and food or other activities in everyday life. Recent work suggests craving can influence how people make decisions and assign value to choice options available to them, yet the neural mechanisms underlying these in...

What is the current status of trial NCT06440577?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-06-18. Estimated completion is 2026-12.

What conditions does trial NCT06440577 study?

This clinical trial studies the following conditions: Decision Making. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06440577?

The interventions under investigation include: Audio-visual stimuli (Neutral-Relaxing) (BEHAVIORAL), Audio-visual stimuli (Drug) (BEHAVIORAL), Audio-visual stimuli (Non-Food) (BEHAVIORAL), Audio-visual stimuli (Food) (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06440577?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 603 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06440577 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial